Examining the effectiveness of intrathecal baclofen on spasticity in individuals with chronic spinal cord injury: A systematic review

Journal of Spinal Cord Medicine

Volumn 37, Issue 1, 2014, Pages 11-18

  McIntyre, Amanda ^a   Mays, Rachel ^a   Mehta, Swati ^a   Janzen, Shannon ^a   Townson, Andrea ^b   Hsieh, Jane ^a   Wolfe, Dalton ^a   Teasell, Robert ^a,c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Activities of daily living; Ashworth scale; Baclofen; Muscle spasticity; Spinal cord injuries

Indexed keywords

BACLOFEN;

ADVERSE DRUG REACTION; CHRONIC DISEASE; CINAHL; DRUG EFFICACY; EMBASE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; IMPLANTABLE PUMP; INFORMATION RETRIEVAL; MEDLINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFLEX; REVIEW; SPASTICITY; SPINAL CORD INJURY;

ACTIVITIES OF DAILY LIVING; ASHWORTH SCALE; BACLOFEN; MUSCLE SPASTICITY; SPINAL CORD INJURIES;

BACLOFEN; HUMANS; INJECTIONS, SPINAL; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; SPINAL CORD INJURIES;

EID: 84893211921     PISSN: 10790268     EISSN: 20457723     Source Type: Journal    
DOI: 10.1179/2045772313Y.0000000102     Document Type: Review

References (23)

1. Rabchevsky AG, Kitzman PH. Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury. Neurotherapeutics 2011;8(2):274-82.
2. Hsieh JTC, Wolfe DL, McIntyre A, Janzen S, Townson AF, Short C, et al. Spasticity following spinal cord injury. In: Eng JJ, Teasell RW, Miller WC, Wolfe DL, Townson AF, Hsieh JTC, et al. (eds.) Spinal cord injury rehabilitation evidence (SCIRE; version 4). London, Ontario: SCIRE; 2012. p. 299-306.
3. Young RR, Delwaide PJ. Drug therapy: spasticity (second of two parts). N Engl J Med 1981;304(2):96-9. (Pubitemid 11170315)
4. Nance P, Schryvers O, Schmidt B, Dubo H, Loveridge B, Fewer D. Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci 1995;22(1):22-9.
5. Novartis Australia. Lioresal® Intrathecal (baclofen). North Ryde, NSW: NOVARTIS Pharmaceuticals Australia Pty Limited; 2012.
6. Coffey RJ, Edgar TS, Francisco GE, Graziani V, Meythaler JM, Ridgely PM, et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 2002;83(6):735-41. (Pubitemid 34721470)
7. Creedon SD, Dijkers MP, Hinderer SR. Intrathecal baclofen for severe spasticity: a meta-analysis. Int J Rehabil Health 1997;3(3): 171-85. (Pubitemid 28020995)
8. Moseley AM, Herbert RD, Sherrington C, Maher CG. Evidence for physiotherapy practice: a survey of the Physiotherapy Evidence Database (PEDro). Aust J Physiother 2002;48(1):43-9. (Pubitemid 34240086)
9. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998;52(6):377-84. (Pubitemid 28438523)
10. Straus SE, Richardson WS, Glasziou P, Haynes RB. Evidence-based medicine: how to practice and teach EBM. Toronto, Ontario: Elsevier Churchill Livingstone; 2005.
11. Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996;77(1):35-9. (Pubitemid 26017489)
12. Burns AS, Meythaler JM. Intrathecal baclofen in tetraplegia of spinal origin: efficacy for upper extremity hypertonia. Spinal Cord 2001;39(8):413-9. (Pubitemid 32769802)
13. Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS. Continuous intrathecal baclofen in spinal cord spasticity. Am J Phys Med Rehabil 1992;71(6):321-7. (Pubitemid 23016783)
14. Coffey RJ, Cahill D, SteersW, Park TS, Ordia J, Meythaler J, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993;78(2): 226-32. (Pubitemid 23039122)
15. Loubster PG, Narayan RK, Sandin KJ, Donovan WH, Russell KD. Continuous infusion of intrathecal baclofen: long-term effects on spasticity and spinal cord injury. Paraplegia 1991; 29(1):48-64.
16. Abel NA, Smith RA. Intrathecal baclofen for treatment of intractable spinal spasticity. Arch Phys Med Rehabil 1994;75(1):54-8. (Pubitemid 24038826)
17. Parke B, Penn RD, Savoy SM, Corcos D. Functional outcome after delivery of intrathecal baclofen. Arch Phys Med Rehabil 1989;70(1):30-2. (Pubitemid 19053880)
18. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540-2.
19. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67(2);206-7. (Pubitemid 17026064)
20. Plassat R, Perrouin Verbe B, Menei P, Menegalli D, Mathe JF, Richard I. Treatment of spasticity with intrathecal baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 2004;42(12):686-93. (Pubitemid 40065532)
21. Ochs G. Intrathecal baclofen. In:Ward CD, (ed.) Rehabilitation of motor disorders. London: Baillere Tindall: Baillere's Clinical Neurology 1993. p. 73-86.
22. Akman MN, Loubser PG, Donovan WH, O'Neill ME, Rossi CD. Intrathecal baclofen: does tolerance occur? Paraplegia 1993;31(8): 516-20. (Pubitemid 23264687)
23. Medical Advisory Secretariat. Intrathecal baclofen pump for spasticity: an evidence-based analysis. Ontario Health Technol Assess Ser 2005;5(7):1-93.